Nanjing Pharmaceutical (600713.SH): "Nanjiao Convertible Bond" will be listed for Trade starting from January 20.

Nanjing Pharmaceutical (600713.SH) announced that the company's 1.081 billion yuan convertible Bonds will be issued on ...

Zhitong FinanceJan 15 04:50 ET

Is NanJing Pharmaceutical (SHSE:600713) Using Too Much Debt?

Simply Wall StDec 12, 2024 22:20 ET

nanjing pharmaceutical (600713.SH) has been approved to register 6 billion yuan of ultra-short-term financing bonds.

Nanjing Pharmaceutical(600713.SH) announced that the company received a notice from Bank of China on October 30, 2024...

Zhitong FinanceOct 31, 2024 03:47 ET

Nanjing Pharmaceutical: Full text of Nanjing Pharmaceutical\'s 2024 third quarter report

SZSIOct 30, 2024 12:00 ET · Announcements

Full text of Nanjing Pharmaceutical\'s 2024 third quarter report

SZSIOct 30, 2024 12:00 ET · Announcements

Nanjing Pharmaceutical (600713.SH) released its performance for the first three quarters, with net income of 0.442 billion yuan, a 0.36% year-on-year increase.

nanjing pharmaceutical (600713.SH) released the third quarter report for 2024, with revenue for the first three quarters reaching 40...

Zhitong FinanceOct 30, 2024 04:02 ET